Ligand validation:5ILY

DPO: DIPHOSPHATE

DPO is a Ligand Of Interest in 5ILY designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5ILY_DPO_A_605	75%	41%	0.106	0.94	0.79	1.49	-	2	0	0	100%	0.8
5IKA_DPO_A_604	86%	42%	0.087	0.955	0.7	1.54	-	3	0	0	100%	1
5IK6_DPO_A_605	52%	47%	0.12	0.876	0.69	1.33	-	2	2	0	100%	1
4RNQ_DPO_A_606	47%	50%	0.112	0.849	0.72	1.18	-	1	0	0	100%	0.55
4DI5_DPO_A_605	13%	55%	0.282	0.827	0.74	1	-	-	3	0	100%	0.64
5KG0_DPO_A_507	100%	51%	0.039	0.99	0.77	1.12	-	1	0	0	100%	0.2
5KFJ_DPO_A_508	100%	52%	0.044	0.991	0.78	1.08	-	1	0	0	100%	0.4
5KFI_DPO_A_508	100%	54%	0.043	0.988	0.73	1.04	-	1	0	0	100%	0.4
5KFL_DPO_A_507	100%	52%	0.043	0.988	0.84	1.03	-	1	0	0	100%	0.6
5KG6_DPO_A_507	100%	46%	0.044	0.989	0.73	1.32	-	1	0	0	100%	10

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.